These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8076367

  • 1. Preclinical data for Droloxifene.
    Hasmann M, Rattel B, Löser R.
    Cancer Lett; 1994 Sep 15; 84(2):101-16. PubMed ID: 8076367
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic and biologic properties of droloxifene, a new antiestrogen.
    Eppenberger U, Wosikowski K, Küng W.
    Am J Clin Oncol; 1991 Sep 15; 14 Suppl 2():S5-14. PubMed ID: 1962598
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Droloxifene, a new antiestrogen: its role in metastatic breast cancer.
    Rauschning W, Pritchard KI.
    Breast Cancer Res Treat; 1994 Sep 15; 31(1):83-94. PubMed ID: 7981460
    [Abstract] [Full Text] [Related]

  • 6. Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, Pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients.
    Helle SI, Anker GB, Tally M, Hall K, Lønning PE.
    J Steroid Biochem Mol Biol; 1996 Feb 15; 57(3-4):167-71. PubMed ID: 8645625
    [Abstract] [Full Text] [Related]

  • 7. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
    Gao HD, Sun JZ, Bi DS, Ma R.
    Ai Zheng; 2003 Apr 15; 22(4):376-9. PubMed ID: 12703992
    [Abstract] [Full Text] [Related]

  • 8. The estrogenic and antiestrogenic activities of droloxifene in human breast cancers.
    Kawamura I, Mizota T, Lacey E, Tanaka Y, Manda T, Shimomura K, Kohsaka M.
    Jpn J Pharmacol; 1993 Sep 15; 63(1):27-34. PubMed ID: 8271528
    [Abstract] [Full Text] [Related]

  • 9. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.
    Labrie F, Labrie C, Bélanger A, Simard J, Gauthier S, Luu-The V, Mérand Y, Giguere V, Candas B, Luo S, Martel C, Singh SM, Fournier M, Coquet A, Richard V, Charbonneau R, Charpenet G, Tremblay A, Tremblay G, Cusan L, Veilleux R.
    J Steroid Biochem Mol Biol; 1999 Sep 15; 69(1-6):51-84. PubMed ID: 10418981
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer.
    Buzdar A, Hayes D, El-Khoudary A, Yan S, Lønning P, Lichinitser M, Gopal R, Falkson G, Pritchard K, Lipton A, Wolter K, Lee A, Fly K, Chew R, Alderdice M, Burke K, Eisenber P, Droloxifene 301 Study Group.
    Breast Cancer Res Treat; 2002 May 15; 73(2):161-75. PubMed ID: 12088118
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Kawamura I, Mizota T, Kondo N, Shimomura K, Kohsaka M.
    Jpn J Pharmacol; 1991 Oct 15; 57(2):215-24. PubMed ID: 1812300
    [Abstract] [Full Text] [Related]

  • 16. Droloxifene--a new anti-estrogen. A phase II study in advanced breast cancer.
    Haarstad H, Gundersen S, Wist E, Raabe N, Mella O, Kvinnsland S.
    Acta Oncol; 1992 Oct 15; 31(4):425-8. PubMed ID: 1632978
    [Abstract] [Full Text] [Related]

  • 17. Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor.
    Görlich M, Winterfeld G, Hauff P, Arnold W, Fichtner I, Staab HJ.
    J Cancer Res Clin Oncol; 1992 Oct 15; 119(2):97-100. PubMed ID: 1429832
    [Abstract] [Full Text] [Related]

  • 18. Binding characteristics of novel nonsteroidal antiestrogens to the rat uterine estrogen receptors.
    Martel C, Provencher L, Li X, St Pierre A, Leblanc G, Gauthier S, Mérand Y, Labrie F.
    J Steroid Biochem Mol Biol; 1998 Feb 15; 64(3-4):199-205. PubMed ID: 9605415
    [Abstract] [Full Text] [Related]

  • 19. Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen.
    Rivera-Gonzalez R, Petersen DN, Tkalcevic G, Thompson DD, Brown TA.
    J Steroid Biochem Mol Biol; 1998 Jan 15; 64(1-2):13-24. PubMed ID: 9569006
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factors in breast cancer.
    Helle SI, Lønning PE.
    Acta Oncol; 1996 Jan 15; 35 Suppl 5():19-22. PubMed ID: 9142960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.